cjc1295 ipamorelin austin and cjc CJC-1295 & Ipamorelin Therapy in cjc-1295 ipamorelin peptide therapy CJC-1295
Description
Lee CC, Suttikhana I, Ashaolu TJ

& Kaplan, J

This finding is sometimes cited to justify ipamorelin use in corticosteroid contexts, but that extrapolation is not supported by available evidence

Patients on chronic corticosteroids may require dose adjustments or careful monitoring of IGF-1 levels to ensure sermorelin is having the desired effect

Latest studies further bind these to ferroptosis-linked lipid peroxidation

[DOI] [PubMed] [Google Scholar] 102.De Gottardi A., Vinciguerra M., Sgroi A., Moukil M., Ravier-DallAntonia F., Pazienza V., Pugnale P., Foti M., Hadengue A